×

Bifurcation analysis of a mathematical model of atopic dermatitis to determine patient-specific effects of treatments on dynamic phenotypes. (English) Zbl 1397.92369

Summary: Atopic dermatitis (AD) is a common inflammatory skin disease, whose incidence is currently increasing worldwide. AD has a complex etiology, involving genetic, environmental, immunological, and epidermal factors, and its pathogenic mechanisms have not yet been fully elucidated. Identification of AD risk factors and systematic understanding of their interactions are required for exploring effective prevention and treatment strategies for AD. We recently developed a mathematical model for AD pathogenesis to clarify mechanisms underlying AD onset and progression. This model describes a dynamic interplay between skin barrier, immune regulation, and environmental stress, and reproduced four types of dynamic behaviour typically observed in AD patients in response to environmental triggers. Here, we analyse bifurcations of the model to identify mathematical conditions for the system to demonstrate transitions between different types of dynamic behaviour that reflect respective severity of AD symptoms. By mathematically modelling effects of topical application of antibiotics, emollients, corticosteroids, and their combinations with different application schedules and doses, bifurcation analysis allows us to mathematically evaluate effects of the treatments on improving AD symptoms in terms of the patients’ dynamic behaviour. The mathematical method developed in this study can be used to explore and improve patient-specific personalised treatment strategies to control AD symptoms.

MSC:

92C50 Medical applications (general)
34C23 Bifurcation theory for ordinary differential equations
92D10 Genetics and epigenetics
PDFBibTeX XMLCite
Full Text: DOI

References:

[1] Bargaje, R.; Trachana, K.; Shelton, M. N.; McGinnis, C. S.; Zhou, J. X.; Chadick, C.; Cook, S.; Cavanaugh, C.; Huang, S.; Hood, L., Cell population structure prior to bifurcation predicts efficiency of directed differentiation in human induced pluripotent cells, Proc. Natl. Acad. Sci., 114, 9, 2271-2276, (2017)
[2] Berke, R.; Singh, A.; Guralnick, M., Atopic dermatitis: an overview., Am. Fam. Physician, 86, 1, 35-42, (2012)
[3] Bernardo, M.; Budd, C.; Champneys, A. R.; Kowalczyk, P., Piecewise-smooth dynamical systems: theory and applications, 163, (2008), Springer Science & Business Media · Zbl 1146.37003
[4] Bieber, T.; Angelo, M.; Akdis, C. A.; Traidl-Hoffmann, C.; Lauener, R.; Schäppi, G.; Schmid-Grendelmeier, P., Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go?, J. Allergy Clin. Immunol., 139, 4, S58-S64, (2017)
[5] Boettiger, C.; Ross, N.; Hastings, A., Early warning signals: the charted and uncharted territories, Theor. Ecol., 6, 3, 255-264, (2013)
[6] Byrd, A. L.; Deming, C.; Cassidy, S. K.; Harrison, O. J.; Ng, W. I.; Conlan, S.; Belkaid, Y.; Segre, J. A.; Kong, H. H.; Program, N. C.S., Staphylococcus aureus and staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis, Sci. Transl. Med., 9, 397, eaal4651, (2017)
[7] Carroll, C. L.; Balkrishnan, R.; Feldman, S. R.; Fleischer, A. B.; Manuel, J. C., The burden of atopic dermatitis: impact on the patient, family, and society, Pediatr. Dermatol., 22, 3, 192-199, (2005)
[8] Celli, S.; Day, M.; Müller, A. J.; Molina-Paris, C.; Lythe, G.; Bousso, P., How many dendritic cells are required to initiate a T-cell response?, Blood, 120, 19, 3945-3948, (2012)
[9] Chen, L.; Liu, R.; Liu, Z. P.; Li, M.; Aihara, K., Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers, Sci. Rep., 2, 342, (2012)
[10] Chieosilapatham, P.; Ogawa, H.; Niyonsaba, F., Current insights into the role of human β-defensins in atopic dermatitis, Clin. Exp. Immunol., (2017)
[11] Christodoulides, P.; Hirata, Y.; Domínguez-Hüttinger, E.; Danby, S. G.; Cork, M. J.; Williams, H. C.; Aihara, K.; Tanaka, R. J., Computational design of treatment strategies for proactive therapy on atopic dermatitis using optimal control theory, Phil. Trans. R. Soc. A, 375, 2096, 20160285, (2017) · Zbl 1404.92008
[12] Domínguez-Hüttinger, E.; Ono, M.; Barahona, M.; Tanaka, R. J., Risk factor-dependent dynamics of atopic dermatitis: modelling multi-scale regulation of epithelium homeostasis, Interface Focus, 3, 2, 20120090, (2013)
[13] Domínguez-Hüttinger, E.; Christodoulides, P.; Miyauchi, K.; Irvine, A. D.; Okada-Hatakeyama, M.; Kubo, M.; Tanaka, R. J., Mathematical modeling of atopic dermatitis reveals “double-switch” mechanisms underlying 4 common disease phenotypes, J. Allergy Clin. Immunol., 139, 6, 1861-1872, (2017)
[14] Eichenfield, L. F.; Ahluwalia, J.; Waldman, A.; Borok, J.; Udkoff, J.; Boguniewicz, M., Current guidelines for the evaluation and management of atopic dermatitis: a comparison of the joint task force practice parameter and American Academy of dermatology guidelines, J. Allergy Clin. Immunol., 139, 4, S49-S57, (2017)
[15] Eichenfield, L. F.; Tom, W. L.; Berger, T. G.; Krol, A.; Paller, A. S.; Schwarzenberger, K.; Bergman, J. N.; Chamlin, S. L.; Cohen, D. E.; Cooper, K. D., Guidelines of care for the management of atopic dermatitis: section 2. management and treatment of atopic dermatitis with topical therapies, J. Am. Acad. Dermatol., 71, 1, 116-132, (2014)
[16] Flohr, C.; Mann, J., New insights into the epidemiology of childhood atopic dermatitis, Allergy, 69, 1, 3-16, (2014)
[17] Frey, U.; Suki, B., Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control, The Lancet, 372, 9643, 1088-1099, (2008)
[18] Green, C.; Colquitt, J.; Kirby, J.; Davidson, P., Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use, Br. J. Dermatol., 152, 1, 130-141, (2005)
[19] Guo, Y.; Li, P.; Tang, J.; Han, X.; Zou, X.; Xu, G.; Xu, Z.; Wei, F.; Liu, Q.; Wang, M., Prevalence of atopic dermatitis in Chinese children aged, Sci. Rep., 1-7, 6, 29751, (2016)
[20] Hirsch, M. W.; Smale, S.; Devaney, R. L., Differential equations, dynamical systems, and an introduction to chaos, (2012), Academic press
[21] Höfer, T.; Nathansen, H.; Löhning, M.; Radbruch, A.; Heinrich, R., GATA-3 transcriptional imprinting in th2 lymphocytes: a mathematical model, Proc. Natl. Acad. Sci., 99, 14, 9364-9368, (2002)
[22] Hoffman, D.; Kroll, L.; Basehoar, A.; Reece, B.; Cunningham, C.; Koenig, D., Immediate and extended effects of sodium lauryl sulphate exposure on stratum corneum natural moisturizing factor, Int. J. Cosmet. Sci., 36, 1, 93-101, (2014)
[23] Howell, M. D.; Kim, B. E.; Gao, P.; Grant, A. V.; Boguniewicz, M.; DeBenedetto, A.; Schneider, L.; Beck, L. A.; Barnes, K. C.; Leung, D. Y., Cytokine modulation of atopic dermatitis filaggrin skin expression, J. Allergy Clin. Immunol., 120, 1, 150-155, (2007)
[24] Huang, Y. J.; Marsland, B. J.; Bunyavanich, S.; O’mahony, L.; Leung, D. Y.; Muraro, A.; Fleisher, T. A., The microbiome in allergic disease: current understanding and future opportunities?2017 practall document of the American Academy of allergy, asthma & immunology and the European Academy of allergy and clinical immunology, J. Allergy Clin. Immunol., 139, 4, 1099-1110, (2017)
[25] Kawakami, H., Bifurcation of periodic responses in forced dynamic nonlinear circuits: computation of bifurcation values of the system parameters, IEEE Trans. Circuits Syst., 31, 3, 248-260, (1984) · Zbl 0548.94035
[26] Kousaka, T.; Ueta, T.; Kawakami, H., Bifurcation of switched nonlinear dynamical systems, IEEE Trans. Circuits Syst. II: Analog Digit. Signal Process., 46, 7, 878-885, (1999) · Zbl 1007.94030
[27] Kuznetsov, Y. A., Elements of applied bifurcation theory, 112, (2013), Springer Science & Business Media
[28] Leyden, J. J.; Marples, R. R.; Kligman, A. M., Staphylococcus aureus in the lesions of atopic dermatitis, Br. J. Dermatol., 90, 5, (1974)
[29] Lin, Y. T.; Wang, C. T.; Chiang, B. L., Role of bacterial pathogens in atopic dermatitis, Clin. Rev. Allergy Immunol., 33, 3, 167-177, (2007)
[30] Meisel, J. S.; Sfyroera, G.; Bartow-McKenney, C.; Gimblet, C.; Bugayev, J.; Horwinski, J.; Kim, B.; Brestoff, J. R.; Tyldsley, A. S.; Zheng, Q., Commensal microbiota modulate gene expression in the skin, Microbiome, 6, 1, 20, (2018)
[31] Nilsson, E. J.; Henning, C. G.; Magnusson, J., Topical corticosteroids and staphylococcus aureus in atopic dermatitis, J. Am. Acad. Dermatol., 27, 1, 29-34, (1992)
[32] Scheffer, M.; Bascompte, J.; Brock, W. A.; Brovkin, V.; Carpenter, S. R.; Dakos, V.; Held, H.; Van Nes, E. H.; Rietkerk, M.; Sugihara, G., Early-warning signals for critical transitions, Nature, 461, 7260, 53-59, (2009)
[33] Shouval, R.; Bondi, O.; Mishan, H.; Shimoni, A.; Unger, R.; Nagler, A., Application of machine learning algorithms for clinical predictive modeling: a data-mining approach in SCT, Bone Marrow Transplant., 49, 3, 332-337, (2014)
[34] Simpson, E. L.; Chalmers, J. R.; Hanifin, J. M.; Thomas, K. S.; Cork, M. J.; McLean, W. I.; Brown, S. J.; Chen, Z.; Chen, Y.; Williams, H. C., Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention, J. Allergy Clin. Immunol., 134, 4, 818-823, (2014)
[35] Taïeb, A.; Seneschal, J.; Mossalayi, M. D., Biologics in atopic dermatitis, JDDG: J. Dtsch. Dermatol.Ges., 10, 3, 174-178, (2012)
[36] Tanaka, G.; Aihara, K., Effects of seasonal variation patterns on recurrent outbreaks in epidemic models, J. Theor. Biol., 317, 87-95, (2013) · Zbl 1368.92192
[37] Tanaka, G.; Tsumoto, K.; Tsuji, S.; Aihara, K., Bifurcation analysis on a hybrid systems model of intermittent hormonal therapy for prostate cancer, Physica D, 237, 20, 2616-2627, (2008) · Zbl 1157.37024
[38] Tanaka, R. J.; Ono, M.; Harrington, H. A., Skin barrier homeostasis in atopic dermatitis: feedback regulation of kallikrein activity, PLoS One, 6, 5, E19895, (2011)
[39] Tang, T. S.; Bieber, T.; Williams, H. C., Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful?, J. Allergy Clin. Immunol., 133, 6, 1615-1625, (2014)
[40] Weidinger, S.; Novak, N., Atopic dermatitis, The Lancet, 387, 10023, 1109-1122., (2016)
[41] Williams, H. C., Atopic dermatitis, N. Engl. J. Med., 352, 22, 2314-2324, (2005)
[42] Zhang, Z.; Clarke, T. B.; Weiser, J. N., Cellular effectors mediating th17-dependent clearance of pneumococcal colonization in mice, J. Clin. Invest., 119, 7, 1899-1909, (2009)
[43] Zimmer, A.; Katzir, I.; Dekel, E.; Mayo, A. E.; Alon, U., Prediction of multidimensional drug dose responses based on measurements of drug pairs, Proc. Natl. Acad. Sci., 113, 37, 10442-10447, (2016)
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.